{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:46:26Z","timestamp":1789713986110,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007136","name":"Secretar\u00eda de Estado de Investigaci\u00f3n, Desarrollo e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2016-75500-R"],"award-info":[{"award-number":["SAF2016-75500-R"]}],"id":[{"id":"10.13039\/501100007136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS13\/01102"],"award-info":[{"award-number":["FIS13\/01102"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","award":["SAM15PINT1514"],"award-info":[{"award-number":["SAM15PINT1514"]}],"id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s12035-018-1096-7","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T18:22:23Z","timestamp":1525371743000},"page":"490-501","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats"],"prefix":"10.1007","volume":"56","author":[{"given":"David","family":"Mart\u00edn-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiram","family":"Tendilla-Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L. M.","family":"Madrigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Garc\u00eda-Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Leza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier R.","family":"Caso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"key":"1096_CR1","unstructured":"Marcus M, Yasamy MT, van Ommeren M, Chisholm D (2012) Depression, a global public health concern. WHO Department of Mental Health and Substance Abuse, pp 1\u20138"},{"issue":"9995","key":"1096_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","volume":"386","author":"Global Burden of Disease Study C","year":"2015","unstructured":"Global Burden of Disease Study C (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386(9995):743\u2013800. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(15)60692-4","journal-title":"Lancet"},{"issue":"10053","key":"1096_CR3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","volume":"388","author":"GBD Disease","year":"2016","unstructured":"Disease GBD, Injury I, Prevalence C (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053):1545\u20131602. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)31678-6","journal-title":"Lancet"},{"issue":"2","key":"1096_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrn1846","volume":"7","author":"O Berton","year":"2006","unstructured":"Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7(2):137\u2013151. \n                    https:\/\/doi.org\/10.1038\/nrn1846","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"1096_CR5","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1176\/appi.ps.201300059","volume":"65","author":"DA Mrazek","year":"2014","unstructured":"Mrazek DA, Hornberger JC, Altar CA, Degtiar I (2014) A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996\u20132013. Psychiatr Serv 65(8):977\u2013987. \n                    https:\/\/doi.org\/10.1176\/appi.ps.201300059","journal-title":"Psychiatr Serv"},{"issue":"1","key":"1096_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16(1):22\u201334. \n                    https:\/\/doi.org\/10.1038\/nri.2015.5","journal-title":"Nat Rev Immunol"},{"issue":"13","key":"1096_CR7","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1523\/JNEUROSCI.5032-08.2009","volume":"29","author":"JC O'Connor","year":"2009","unstructured":"O'Connor JC, Andre C, Wang Y, Lawson MA, Szegedi SS, Lestage J, Castanon N, Kelley KW et al (2009) Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci 29(13):4200\u20134209. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.5032-08.2009","journal-title":"J Neurosci"},{"issue":"4","key":"1096_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/mp.2009.116","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, Spivey JR, Saito K et al (2010) CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 15(4):393\u2013403. \n                    https:\/\/doi.org\/10.1038\/mp.2009.116","journal-title":"Mol Psychiatry"},{"issue":"3","key":"1096_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","volume":"36","author":"R Dantzer","year":"2011","unstructured":"Dantzer R, O'Connor JC, Lawson MA, Kelley KW (2011) Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 36(3):426\u2013436. \n                    https:\/\/doi.org\/10.1016\/j.psyneuen.2010.09.012","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"1096_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47(4):351\u2013354. \n                    https:\/\/doi.org\/10.1016\/S0006-3223(99)00230-9","journal-title":"Biol Psychiatry"},{"issue":"6381","key":"1096_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/358036a0","volume":"358","author":"T Kutsuwada","year":"1992","unstructured":"Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H et al (1992) Molecular diversity of the NMDA receptor channel. Nature 358(6381):36\u201341. \n                    https:\/\/doi.org\/10.1038\/358036a0","journal-title":"Nature"},{"issue":"5060","key":"1096_CR12","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1126\/science.256.5060.1217","volume":"256","author":"H Monyer","year":"1992","unstructured":"Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B et al (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256(5060):1217\u20131221. \n                    https:\/\/doi.org\/10.1126\/science.256.5060.1217","journal-title":"Science"},{"issue":"10","key":"1096_CR13","doi-asserted-by":"publisher","first-page":"e0138904","DOI":"10.1371\/journal.pone.0138904","volume":"10","author":"T Liu","year":"2015","unstructured":"Liu T, Zhong S, Liao X, Chen J, He T, Lai S, Jia Y (2015) A meta-analysis of oxidative stress markers in depression. PLoS One 10(10):e0138904. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0138904","journal-title":"PLoS One"},{"key":"1096_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuropharm.2015.11.029","volume":"103","author":"D Martin-Hernandez","year":"2016","unstructured":"Martin-Hernandez D, Bris AG, MacDowell KS, Garcia-Bueno B, Madrigal JL, Leza JC, Caso JR (2016) Modulation of the antioxidant nuclear factor (erythroid 2-derived)-like 2 pathway by antidepressants in rats. Neuropharmacology 103:79\u201391. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2015.11.029","journal-title":"Neuropharmacology"},{"issue":"1","key":"1096_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41537-017-0037-1","volume":"3","author":"SM O'Donovan","year":"2017","unstructured":"O'Donovan SM, Sullivan CR, McCullumsmith RE (2017) The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders. NPJ Schizophr 3(1):32. \n                    https:\/\/doi.org\/10.1038\/s41537-017-0037-1","journal-title":"NPJ Schizophr"},{"issue":"7","key":"1096_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrd.2017.16","volume":"16","author":"JW Murrough","year":"2017","unstructured":"Murrough JW, Abdallah CG, Mathew SJ (2017) Targeting glutamate signalling in depression: progress and prospects. Nat Rev Drug Discov 16(7):472\u2013486. \n                    https:\/\/doi.org\/10.1038\/nrd.2017.16","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"1096_CR17","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.neubiorev.2012.07.001","volume":"36","author":"MN Hill","year":"2012","unstructured":"Hill MN, Hellemans KG, Verma P, Gorzalka BB, Weinberg J (2012) Neurobiology of chronic mild stress: parallels to major depression. Neurosci Biobehav Rev 36(9):2085\u20132117. \n                    https:\/\/doi.org\/10.1016\/j.neubiorev.2012.07.001","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"1096_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/npp.2014.176","volume":"40","author":"P Patricio","year":"2015","unstructured":"Patricio P, Mateus-Pinheiro A, Irmler M, Alves ND, Machado-Santos AR, Morais M, Correia JS, Korostynski M et al (2015) Differential and converging molecular mechanisms of antidepressants\u2019 action in the hippocampal dentate gyrus. Neuropsychopharmacology 40(2):338\u2013349. \n                    https:\/\/doi.org\/10.1038\/npp.2014.176","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"1096_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/0976-500X.72351","volume":"1","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. J Pharmacol Exp Ther 1(2):94\u201399. \n                    https:\/\/doi.org\/10.4103\/0976-500X.72351","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"1096_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000087097","volume":"52","author":"P Willner","year":"2005","unstructured":"Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52(2):90\u2013110. \n                    https:\/\/doi.org\/10.1159\/000087097","journal-title":"Neuropsychobiology"},{"issue":"3","key":"1096_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/ALN.0b013e3182657b3e","volume":"117","author":"L Bravo","year":"2012","unstructured":"Bravo L, Mico JA, Rey-Brea R, Perez-Nievas B, Leza JC, Berrocoso E (2012) Depressive-like states heighten the aversion to painful stimuli in a rat model of comorbid chronic pain and depression. Anesthesiology 117(3):613\u2013625. \n                    https:\/\/doi.org\/10.1097\/ALN.0b013e3182657b3e","journal-title":"Anesthesiology"},{"key":"1096_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neuropharm.2015.12.003","volume":"103","author":"D Martin-Hernandez","year":"2016","unstructured":"Martin-Hernandez D, Caso JR, Bris AG, Maus SR, Madrigal JL, Garcia-Bueno B, MacDowell KS, Alou L et al (2016) Bacterial translocation affects intracellular neuroinflammatory pathways in a depression-like model in rats. Neuropharmacology 103:122\u2013133. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2015.12.003","journal-title":"Neuropharmacology"},{"issue":"6","key":"1096_CR23","first-page":"785","volume":"59","author":"M Kusmider","year":"2007","unstructured":"Kusmider M, Solich J, Palach P, Dziedzicka-Wasylewska M (2007) Effect of citalopram in the modified forced swim test in rats. Pharmacol Rep 59(6):785\u2013788","journal-title":"Pharmacol Rep"},{"issue":"2","key":"1096_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s002130050555","volume":"136","author":"JP Reneric","year":"1998","unstructured":"Reneric JP, Lucki I (1998) Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology 136(2):190\u2013197. \n                    https:\/\/doi.org\/10.1007\/s002130050555","journal-title":"Psychopharmacology"},{"key":"1096_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1742-2094-8-151","volume":"8","author":"I Garate","year":"2011","unstructured":"Garate I, Garcia-Bueno B, Madrigal JL, Bravo L, Berrocoso E, Caso JR, Mico JA, Leza JC (2011) Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. J Neuroinflammation 8:151. \n                    https:\/\/doi.org\/10.1186\/1742-2094-8-151","journal-title":"J Neuroinflammation"},{"issue":"15","key":"1096_CR26","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, Rozen SG (2012) Primer3\u2014new capabilities and interfaces. Nucleic Acids Res 40(15):e115. \n                    https:\/\/doi.org\/10.1093\/nar\/gks596","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1096_CR27","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D (2002) The human genome browser at UCSC. Genome Res 12(6):996\u20131006. \n                    https:\/\/doi.org\/10.1101\/gr.229102","journal-title":"Genome Res"},{"key":"1096_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbi.2015.02.007","volume":"46","author":"J Savitz","year":"2015","unstructured":"Savitz J, Drevets WC, Wurfel BE, Ford BN, Bellgowan PS, Victor TA, Bodurka J, Teague TK et al (2015) Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder. Brain Behav Immun 46:55\u201359. \n                    https:\/\/doi.org\/10.1016\/j.bbi.2015.02.007","journal-title":"Brain Behav Immun"},{"issue":"32","key":"1096_CR29","doi-asserted-by":"publisher","first-page":"5151","DOI":"10.2174\/1381612819666140110120435","volume":"20","author":"YH Dang","year":"2014","unstructured":"Dang YH, Ma XC, Zhang JC, Ren Q, Wu J, Gao CG, Hashimoto K (2014) Targeting of NMDA receptors in the treatment of major depression. Curr Pharm Des 20(32):5151\u20135159. \n                    https:\/\/doi.org\/10.2174\/1381612819666140110120435","journal-title":"Curr Pharm Des"},{"issue":"1","key":"1096_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1684\/ecn.2015.0362","volume":"26","author":"YN Liu","year":"2015","unstructured":"Liu YN, Peng YL, Liu L, Wu TY, Zhang Y, Lian YJ, Yang YY, Kelley KW et al (2015) TNFalpha mediates stress-induced depression by upregulating indoleamine 2,3-dioxygenase in a mouse model of unpredictable chronic mild stress. Eur Cytokine Netw 26(1):15\u201325. \n                    https:\/\/doi.org\/10.1684\/ecn.2015.0362","journal-title":"Eur Cytokine Netw"},{"issue":"20","key":"1096_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399406000068","volume":"8","author":"JP Ruddick","year":"2006","unstructured":"Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA (2006) Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med 8(20):1\u201327. \n                    https:\/\/doi.org\/10.1017\/S1462399406000068","journal-title":"Expert Rev Mol Med"},{"issue":"9","key":"1096_CR32","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1007\/s11064-016-1940-y","volume":"41","author":"A Sekine","year":"2016","unstructured":"Sekine A, Kuroki Y, Urata T, Mori N, Fukuwatari T (2016) Inhibition of large neutral amino acid transporters suppresses kynurenic acid production via inhibition of kynurenine uptake in rodent brain. Neurochem Res 41(9):2256\u20132266. \n                    https:\/\/doi.org\/10.1007\/s11064-016-1940-y","journal-title":"Neurochem Res"},{"key":"1096_CR33","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1006\/cyto.1999.0661","volume":"12","author":"TA Babcock","year":"2000","unstructured":"Babcock TA, Carlin JM (2000) Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells. Cytokine 12:588\u2013594. \n                    https:\/\/doi.org\/10.1006\/cyto.1999.0661","journal-title":"Cytokine"},{"key":"1096_CR34","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/sj.mp.4000995","volume":"7","author":"L Capuron","year":"2002","unstructured":"Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R (2002) Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 7:468\u2013473. \n                    https:\/\/doi.org\/10.1038\/sj.mp.4000995","journal-title":"Mol Psychiatry"},{"issue":"6","key":"1096_CR35","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/sj.npp.1301252","volume":"32","author":"B Garcia-Bueno","year":"2007","unstructured":"Garcia-Bueno B, Caso JR, Perez-Nievas BG, Lorenzo P, Leza JC (2007) Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats. Neuropsychopharmacology 32(6):1251\u20131260. \n                    https:\/\/doi.org\/10.1038\/sj.npp.1301252","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"1096_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0006-8993(03)02892-0","volume":"979","author":"JL Madrigal","year":"2003","unstructured":"Madrigal JL, Caso JR, de Cristobal J, Cardenas A, Leza JC, Lizasoain I, Lorenzo P, Moro MA (2003) Effect of subacute and chronic immobilisation stress on the outcome of permanent focal cerebral ischaemia in rats. Brain Res 979(1\u20132):137\u2013145. \n                    https:\/\/doi.org\/10.1016\/S0006-8993(03)02892-0","journal-title":"Brain Res"},{"key":"1096_CR37","doi-asserted-by":"publisher","first-page":"15653","DOI":"10.1073\/pnas.0507901102","volume":"102","author":"PV Choudary","year":"2005","unstructured":"Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, Myers RM, Bunney WE Jr et al (2005) Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A 102:15653\u201315658. \n                    https:\/\/doi.org\/10.1073\/pnas.0507901102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1096_CR38","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.neuropharm.2009.09.005","volume":"58","author":"M Zink","year":"2010","unstructured":"Zink M, Vollmayr B, Gebicke-Haerter PJ, Henn FA (2010) Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression. Neuropharmacology 58(2):465\u2013473. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2009.09.005","journal-title":"Neuropharmacology"},{"key":"1096_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuroscience.2013.04.031","volume":"250","author":"XH Zhang","year":"2013","unstructured":"Zhang XH, Jia N, Zhao XY, Tang GK, Guan LX, Wang D, Sun HL, Li H et al (2013) Involvement of pGluR1, EAAT2 and EAAT3 in offspring depression induced by prenatal stress. Neuroscience 250:333\u2013341. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2013.04.031","journal-title":"Neuroscience"},{"issue":"6","key":"1096_CR40","first-page":"441","volume":"52","author":"K Golembiowska","year":"2000","unstructured":"Golembiowska K, Dziubina A (2000) Effect of acute and chronic administration of citalopram on glutamate and aspartate release in the rat prefrontal cortex. Pol J Pharmacol 52(6):441\u2013448","journal-title":"Pol J Pharmacol"},{"issue":"2","key":"1096_CR41","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.pnpbp.2010.12.029","volume":"35","author":"TY Lin","year":"2011","unstructured":"Lin TY, Yang TT, Lu CW, Wang SJ (2011) Inhibition of glutamate release by bupropion in rat cerebral cortex nerve terminals. Prog Neuro-Psychopharmacol Biol Psychiatry 35(2):598\u2013606. \n                    https:\/\/doi.org\/10.1016\/j.pnpbp.2010.12.029","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1","key":"1096_CR42","doi-asserted-by":"publisher","first-page":"e8566","DOI":"10.1371\/journal.pone.0008566","volume":"5","author":"L Musazzi","year":"2010","unstructured":"Musazzi L, Milanese M, Farisello P, Zappettini S, Tardito D, Barbiero VS, Bonifacino T, Mallei A et al (2010) Acute stress increases depolarization-evoked glutamate release in the rat prefrontal\/frontal cortex: the dampening action of antidepressants. PLoS One 5(1):e8566. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0008566","journal-title":"PLoS One"},{"issue":"1","key":"1096_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","volume":"62","author":"G Sanacora","year":"2012","unstructured":"Sanacora G, Treccani G, Popoli M (2012) Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62(1):63\u201377. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2011.07.036","journal-title":"Neuropharmacology"},{"issue":"11","key":"1096_CR44","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","volume":"62","author":"K Hashimoto","year":"2007","unstructured":"Hashimoto K, Sawa A, Iyo M (2007) Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 62(11):1310\u20131316. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2007.03.017","journal-title":"Biol Psychiatry"},{"issue":"12","key":"1096_CR45","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3109\/13880201003789440","volume":"48","author":"JS Lou","year":"2010","unstructured":"Lou JS, Li CY, Yang XC, Fang J, Yang YX, Guo JY (2010) Protective effect of gan mai da zao decoction in unpredictable chronic mild stress-induced behavioral and biochemical alterations. Pharm Biol 48(12):1328\u20131336. \n                    https:\/\/doi.org\/10.3109\/13880201003789440","journal-title":"Pharm Biol"},{"issue":"1","key":"1096_CR46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pnpbp.2008.10.005","volume":"33","author":"AM Feyissa","year":"2009","unstructured":"Feyissa AM, Chandran A, Stockmeier CA, Karolewicz B (2009) Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 33(1):70\u201375. \n                    https:\/\/doi.org\/10.1016\/j.pnpbp.2008.10.005","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1","key":"1096_CR47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neuroscience.2010.04.035","volume":"169","author":"E Ampuero","year":"2010","unstructured":"Ampuero E, Rubio FJ, Falcon R, Sandoval M, Diaz-Veliz G, Gonzalez RE, Earle N, Dagnino-Subiabre A et al (2010) Chronic fluoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in the rat cerebral cortex. Neuroscience 169(1):98\u2013108. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2010.04.035","journal-title":"Neuroscience"},{"key":"1096_CR48","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neuropharm.2017.01.033","volume":"117","author":"M Erburu","year":"2017","unstructured":"Erburu M, Munoz-Cobo I, Diaz-Perdigon T, Mellini P, Suzuki T, Puerta E, Tordera RM (2017) SIRT2 inhibition modulate glutamate and serotonin systems in the prefrontal cortex and induces antidepressant-like action. Neuropharmacology 117:195\u2013208. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2017.01.033","journal-title":"Neuropharmacology"},{"issue":"5","key":"1096_CR49","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/npp.2012.246","volume":"38","author":"J Burgdorf","year":"2013","unstructured":"Burgdorf J, Zhang XL, Nicholson KL, Balster RL, Leander JD, Stanton PK, Gross AL, Kroes RA et al (2013) GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology 38(5):729\u2013742. \n                    https:\/\/doi.org\/10.1038\/npp.2012.246","journal-title":"Neuropsychopharmacology"},{"issue":"7604","key":"1096_CR50","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, Alkondon M, Yuan P et al (2016) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533(7604):481\u2013486. \n                    https:\/\/doi.org\/10.1038\/nature17998","journal-title":"Nature"},{"issue":"2","key":"1096_CR51","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1471-4159.2008.05642.x","volume":"107","author":"E Toth","year":"2008","unstructured":"Toth E, Gersner R, Wilf-Yarkoni A, Raizel H, Dar DE, Richter-Levin G, Levit O, Zangen A (2008) Age-dependent effects of chronic stress on brain plasticity and depressive behavior. J Neurochem 107(2):522\u2013532. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05642.x","journal-title":"J Neurochem"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1096-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1096-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1096-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T19:09:43Z","timestamp":1556824183000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1096-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,3]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["1096"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1096-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,3]]},"assertion":[{"value":"22 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors provide full disclosure of any and all biomedical financial interests.The authors declare that there are not conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}